{"id":822303,"date":"2022-09-23T20:09:09","date_gmt":"2022-09-23T18:09:09","guid":{"rendered":"https:\/\/15.161.165.86\/non-categorizzato\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/"},"modified":"2022-09-23T20:09:09","modified_gmt":"2022-09-23T18:09:09","slug":"leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/","title":{"rendered":"Leuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients"},"content":{"rendered":"BOSTON--(BUSINESS WIRE)--Leuko, an MIT startup developing PointCheckTM, the first solution that enables at-home noninvasive white blood cell (WBC) monitoring, today announced a first closing of $5 million for their Series A round. The new funding, from HTH VC, Good Growth Capital, IAG Capital Partners, Nina Capital, and angel investors, will accelerate Leuko\u2019s clinical trials to obtain regulatory approval in collaboration with leading cancer centers, including Boston Medical Center and MD Anderson in the USA, and Dexeus and Hospital 12 de Octubre in Europe. Leuko will also continue to pursue its go-to-market and partnership activities with healthcare providers, medical device distributors and pharmaceutical companies.\n\n\n\n\u201cLow WBC levels
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

BOSTON–(BUSINESS WIRE)–Leuko, an MIT startup developing PointCheckTM, the first solution that enables at-home noninvasive white blood cell (WBC) monitoring, today announced a first closing of $5 million for their Series A round. The new funding, from HTH VC, Good Growth Capital, IAG Capital Partners, Nina Capital, and angel investors, will accelerate Leuko\u2019s clinical trials to […]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-822303","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"\nLeuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Leuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients - BeBeez\" \/>\n<meta property=\"og:description\" content=\"BOSTON--(BUSINESS WIRE)--Leuko, an MIT startup developing PointCheckTM, the first solution that enables at-home noninvasive white blood cell (WBC) monitoring, today announced a first closing of $5 million for their Series A round. The new funding, from HTH VC, Good Growth Capital, IAG Capital Partners, Nina Capital, and angel investors, will accelerate Leuko\u2019s clinical trials to […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-23T18:09:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Leuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients\",\"datePublished\":\"2022-09-23T18:09:09+00:00\",\"dateModified\":\"2022-09-23T18:09:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/\"},\"wordCount\":605,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/\",\"name\":\"Leuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-09-23T18:09:09+00:00\",\"dateModified\":\"2022-09-23T18:09:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Leuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Leuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/","og_locale":"en_US","og_type":"article","og_title":"Leuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients - BeBeez","og_description":"BOSTON--(BUSINESS WIRE)--Leuko, an MIT startup developing PointCheckTM, the first solution that enables at-home noninvasive white blood cell (WBC) monitoring, today announced a first closing of $5 million for their Series A round. The new funding, from HTH VC, Good Growth Capital, IAG Capital Partners, Nina Capital, and angel investors, will accelerate Leuko\u2019s clinical trials to […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/","og_site_name":"BeBeez","article_published_time":"2022-09-23T18:09:09+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/"},"author":{"name":"","@id":""},"headline":"Leuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients","datePublished":"2022-09-23T18:09:09+00:00","dateModified":"2022-09-23T18:09:09+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/"},"wordCount":605,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/","name":"Leuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-09-23T18:09:09+00:00","dateModified":"2022-09-23T18:09:09+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Leuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/822303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=822303"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/822303\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=822303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=822303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=822303"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=822303"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=822303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}